Methotrexate Sodium
- Product NDC
- 70518-2711
- 11-digit product format
- 705182711
- Labeler code
- 70518
- Product ID
- 70518-2711_d6e660a2-936a-dba0-e053-2995a90a4442
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Methotrexate Sodium
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA040054
- Marketing category
- ANDA
- Marketing start
- 2020-04-27
- Marketing end
- 0000-00-00
- Substance
- METHOTREXATE SODIUM
- Active strength
- 3 mg/1
- Pharmacologic classes
- Folate Analog Metabolic Inhibitor [EPC], Folic Acid Metabolism Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-2711-0 | 70518271100 | 30 TABLET in 1 BLISTER PACK (70518-2711-0) | 30 tablet | 2020-04-27 | 0000-00-00 | No | No | Current |